Skip to content


Exit type:
Trade Sale

Mologic Limited is a world leading innovator in lateral flow and rapid diagnostic technologies, and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral flow technology.

This positive cash exit, with more than 75% of the consideration payable immediately, delivers returns of up to 3.6x on Calculus equity investments. In addition, further consideration is payable in the event of strong sales of certain of Mologic’s products.